Showing results (191-200 of 255) with videos related to

Sort By:
Pageof 26
Journal of the American Heart Association|April 28, 2026
Sex Differences in Prognostic Implications of CYP2C19 Genotype After Drug-Eluting Stent ImplantationSoo-Jin Kim, Ae-Young Her, Hyung Joon Joo, et al.
The American Journal of Cardiology|July 9, 2014
Usefulness of intravascular ultrasound guidance in percutaneous coronary intervention with second-generation drug-eluting stents for chronic total occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry)Sung-Jin Hong, Byeong-Keuk Kim, Dong-Ho Shin, et al.
The Tohoku Journal of Experimental Medicine|December 9, 2016
Treatment Outcomes of Patients Treated for Pulmonary Tuberculosis after Undergoing GastrectomyIn Young Jung, Moo Hyun Kim, Woo Yong Jeong, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 7, 2005
Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis modelWeon Kim, Myung Ho Jeong, Kwang Soo Cha, et al.
Heart and Vessels|December 22, 2025
Sex differences in long-term outcomes by platelet reactivity in patients with chronic kidney diseaseYong Hoon Kim, Ae-Young Her, Hyung Joon Joo, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|December 19, 2025
Sex differences in platelet reactivity and five-year outcomes with extended dual antiplatelet therapy after drug-eluting stent implantationYong Hoon Kim, Ae-Young Her, Hyung Joon Joo, et al.
HIV Medicine|July 15, 2021
Trends of age-related non-communicable diseases in people living with HIV and comparison with uninfected controls: A nationwide population-based study in South KoreaJung Ho Kim, Juhwan Noh, Woojin Kim, et al.
Journal of Atherosclerosis and Thrombosis|April 19, 2021
Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACTHidenori Arai, Hideaki Bujo, Daisaku Masuda, et al.
Clinical Therapeutics|December 6, 2011
Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority studySeok-Min Kang, Jong-Chan Youn, Shung Chull Chae, et al.
Journal of the American Heart Association|April 29, 2023
Sex Differences in Midterm Prognostic Implications of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents in East Asian Patients: Results From the PTRG-DES (Platelet Function and Genotype-Related Long-Term Prognosis in Drug-Eluting Stent-Treated Patients With Coronary Artery Disease) ConsortiumSoo-Jin Kim, Ae-Young Her, Young-Hoon Jeong, et al.
Pageof 26